Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/46531
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Arikan, Cuneyt | - |
dc.contributor.author | Yilmaz, Atakan | - |
dc.contributor.author | Ozen, Mert | - |
dc.contributor.author | Seyit, Murat | - |
dc.contributor.author | Turkcuer, Ibrahim | - |
dc.contributor.author | Demirozogul, Ezgi | - |
dc.date.accessioned | 2023-01-09T21:12:27Z | - |
dc.date.available | 2023-01-09T21:12:27Z | - |
dc.date.issued | 2021 | - |
dc.identifier.issn | 1334-5605 | - |
dc.identifier.issn | 1845-206X | - |
dc.identifier.uri | https://doi.org/10.22514/sv.2021.040 | - |
dc.identifier.uri | https://hdl.handle.net/11499/46531 | - |
dc.description.abstract | Background: Treatment provided in an emergency department is aimed at alleviating pain immediately with minimized adverse effects as well as warding off further migraine attacks. The primary aim of this article is to compare the effectiveness of oral paracetamol versus zolmitriptan in treating acute migraine attacks. Methods: This prospective, randomized, and controlled study was carried out at a tertiary care hospital visited by 95,000 patients annually. The study recruited 200 participants who were randomized into two groups. One group received 1000 mg paracetamol while the other group received 2.5 mg zolmitriptan orally. Baseline pain scores were recorded using the Visual Analogue Scale (VAS) and Numeric Rating Scale (NRS) at 15, 30 and at 60 min following administration of the study drugs. Patients requiring further treatment were provided fentanyl at a dosage of 1 mu g/kg as a rescue therapy. Results: A significant decrease was evident in VAS and NRS scores following the administration of the study drugs in both groups (P < 0.001). The change in VAS pain scores after 15, 30 and 60 min was calculated as 17.0 +/- 13.9, 41.2 +/- 16.3 and 61.2 +/- 17.5 mm, respectively, in the paracetamol group and 14.2 +/- 11.7, 39.2 +/- 17.9 and 59.2 +/- 19.3 mm, respectively, in the zolmitriptan group, which did not indicate significant differences (P = 0.103, P = 0.425, P = 0.483, respectively). Likewise, NRS pain scores showed a downward trend in line with VAS pain scores and did not yield a significant difference (P = 0.422). No significant difference concerning rescue therapy was noted between the two groups (P = 0.596). Conclusion: Oral paracetamol and zolmitriptan prove to be similarly effective and have low incidence of acute side effects in treating acute migraine cases without aura. | en_US |
dc.description.sponsorship | Pamukkale University Scientific Research Project Unit [2015TPF039] | en_US |
dc.description.sponsorship | This work was supported by the Pamukkale University Scientific Research Project Unit (Numbered 2015TPF039). | en_US |
dc.language.iso | en | en_US |
dc.publisher | Mre Press | en_US |
dc.relation.ispartof | Signa Vitae | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Emergency department | en_US |
dc.subject | Migraine | en_US |
dc.subject | Paracetamol | en_US |
dc.subject | Zolmitriptan | en_US |
dc.subject | Clinical Pharmacokinetics | en_US |
dc.subject | United-States | en_US |
dc.subject | 311c90 | en_US |
dc.subject | Impact | en_US |
dc.subject | Tolerability | en_US |
dc.subject | Prevalence | en_US |
dc.subject | Headache | en_US |
dc.title | Oral paracetamol versus zolmitriptan to treat acute migraine attack in the emergency department | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 17 | en_US |
dc.identifier.issue | 5 | en_US |
dc.identifier.startpage | 110 | en_US |
dc.identifier.endpage | 116 | en_US |
dc.authorid | Arıkan, Cüneyt/0000-0001-6823-5357 | - |
dc.identifier.doi | 10.22514/sv.2021.040 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.authorscopusid | 57203267624 | - |
dc.authorscopusid | 55554611400 | - |
dc.authorscopusid | 36993995700 | - |
dc.authorscopusid | 48161777700 | - |
dc.authorscopusid | 14011949400 | - |
dc.authorscopusid | 57203263452 | - |
dc.authorwosid | Arıkan, Cüneyt/GVT-8872-2022 | - |
dc.identifier.scopus | 2-s2.0-85115297296 | en_US |
dc.identifier.wos | WOS:000697049100016 | en_US |
dc.identifier.scopusquality | Q3 | - |
item.openairetype | Article | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | With Fulltext | - |
item.grantfulltext | open | - |
item.cerifentitytype | Publications | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
Appears in Collections: | Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
File | Size | Format | |
---|---|---|---|
SV2021011903.pdf | 797.94 kB | Adobe PDF | View/Open |
CORE Recommender
Page view(s)
28
checked on Aug 24, 2024
Download(s)
14
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.